Compound Summary
Compound Name: | Hispidol |
Compound CID: | 5281254 |
Synonyms: | Hispidol 5786-54-9 6,4-DIHYDROXYAURONE UNII-CS1235I0WT (Z)-4,6-Dihydroxyaurone More... |
Iupac Name: | (2Z)-6-hydroxy-2-[(4-hydroxyphenyl)methylidene]-1-benzofuran-3-one |
InChI: | InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)7-14-15(18)12-6-5-11(17)8-13(12)19-14/h1-8,16-17H/b14-7- |
InChIKey: | KEZLDSPIRVZOKZ-AUWJEWJLSA-N |
Canonical Smiles: | C1=CC(=CC=C1C=C2C(=O)C3=C(O2)C=C(C=C3)O)O |
Isomeric Smiles: | C1=CC(=CC=C1/C=C\2/C(=O)C3=C(O2)C=C(C=C3)O)O |
Molecular Weight: | 254.24 |
Molecular Formula: | C15H10O4 |
Molecular Weight: | 254.24 |
Molecular Formula: | C15H10O4 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 19 |
Complexity: | 382 |
Hispidol | Hispidol |
---|---|
Hispidol |
5786-54-9 |
6,4-DIHYDROXYAURONE |
UNII-CS1235I0WT |
(Z)-4,6-Dihydroxyaurone |
CHEBI:5731 |
CHEMBL426110 |
CS1235I0WT |
(2Z)-6-hydroxy-2-(4-hydroxyphenyl)methylidene-1-benzofuran-3-one |
NSC356828 |
3(2H)-Benzofuranone, 6-hydroxy-2-((4-hydroxyphenyl)methylene)-, (2Z)- |
3(2H)-Benzofuranone, 6-hydroxy-2-(4-hydroxyphenyl)methylene-, (2Z)- |
ZE-Hispidol |
4,6-Dihydroxyaurone" |
6,4 -dihydroxy aurone |
Isoliquiritigenin metabolite M6 |
SCHEMBL5707753 |
BDBM50180260 |
ZINC13481340 |
AKOS001354021 |
CS-7503 |
NSC 356828 |
NSC-356828 |
HY-102040 |
C08644 |
AB00767717-01 |
Benzofuran-6-ol-3-one, 2-4-hydroxybenzylidene- |
Q27106875 |
2-(4-Hydroxybenzylidene)-6-hydroxybenzofuran-3(2H)-one |
(2Z)-6-hydroxy-2-(4-hydroxyphenyl)methylenebenzofuran-3-one |
(Z)-2-(4-hydroxybenzylidene)-6-hydroxybenzofuran-3(2H)-one |
(2Z)-6-Hydroxy-2-((4-hydroxyphenyl)methylene)-3(2H)-benzofuranone |
2-((4-Hydroxyphenyl)methylidene)-6-oxidanyl-1-benzofuran-3-one |
(2Z)-6-Hydroxy-2-(4-hydroxybenzylidene)-1-benzofuran-3(2H)-one # |
(2Z)-6-hydroxy-2-(4-hydroxyphenyl)methylidene-1-benzofuran-3(2H)-one |
(2Z)-6-hydroxy-2-(4-hydroxyphenyl)methylidene-2,3-dihydro-1-benzofuran-3-one |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 25.000000000000000 | umol/L | 17.240000000000000 | 21.600000000000000 | 0.250000000000000 | S | N2 | 33179346 | Active | ||||
Caenorhabditis elegans | 12.500000000000000 | umol/L | 17.240000000000000 | 18.560000000000000 | 0.080000000000000 | S | N2 | 33179346 | Active | ||||
Caenorhabditis elegans | 50.000000000000000 | umol/L | 17.240000000000000 | 22.640000000000000 | 0.310000000000000 | S | N2 | 33179346 | Active |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 0.310000000000000 | 1 | 3 |